Found: 11
Select item for more details and to access through your institution.
Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience.
- Published in:
- Journal of Personalized Medicine, 2024, v. 14, n. 7, p. 718, doi. 10.3390/jpm14070718
- By:
- Publication type:
- Article
Drug survival und klinische Wirksamkeit von Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab und Tildrakizumab in der Behandlung der Psoriasis: Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2024, v. 22, n. 1, p. 34, doi. 10.1111/ddg.15251_g
- By:
- Publication type:
- Article
Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2024, v. 22, n. 1, p. 34, doi. 10.1111/ddg.15251
- By:
- Publication type:
- Article
Melanoma Management during the COVID-19 Pandemic Emergency: A Literature Review and Single-Center Experience.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6071, doi. 10.3390/cancers13236071
- By:
- Publication type:
- Article
"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 12, p. 2187, doi. 10.1111/exd.14731
- By:
- Publication type:
- Article
Comparison between brodalumab, secukinumab and ixekizumab effectiveness and drug survival: A real‐life experience on 638 patients with psoriasis.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 9, p. 1591, doi. 10.1111/exd.14874
- By:
- Publication type:
- Article
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effectiveness of Brodalumab on Scalp, Palmoplantar, and Genital Psoriasis: A Descriptive Pilot Study.
- Published in:
- Dermatologic Therapy, 2023, p. 1, doi. 10.1155/2023/1793535
- By:
- Publication type:
- Article
Tildrakizumab in real‐life shows good efficacy in moderate‐to‐severe psoriasis regardless of previous use of biologic drugs and joint involvement.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15818
- By:
- Publication type:
- Article
Dual‐targeted therapy with apremilast and vedolizumab in pyoderma gangrenosum associated with Crohn's disease.
- Published in:
- Journal of Dermatology, 2020, v. 47, n. 6, p. e216, doi. 10.1111/1346-8138.15283
- By:
- Publication type:
- Article
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 4, p. 379, doi. 10.1093/ced/llac098
- By:
- Publication type:
- Article